CoChat

The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia

Open access
Schuijt, Tim J, Lankelma, Jacqueline M, Scicluna, Brendon P, de Sousa e Melo, Felipe, Roelofs, Joris J T H, de Boer, J Daan, Hoogendijk, Arjan J, de Beer, Regina, de Vos, Alex, Belzer, Clara, de Vos, Willem M, van der Poll, Tom, Wiersinga, W Joost · 2016 · Gut

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Objective: Pneumonia accounts for more deaths than any other infectious disease worldwide. The intestinal microbiota supports local mucosal immunity and is increasingly recognised as an important modulator of the systemic immune system. The precise role of the gut microbiota in bacterial pneumonia, however, is unknown. Here, we investigate the function of the gut microbiota in the host defence against Streptococcus pneumoniae infections. Design: We depleted the gut microbiota in C57BL/6 mice and subsequently infected them intranasally with S. pneumoniae . We then performed survival and faecal microbiota transplantation (FMT) experiments and measured parameters of inflammation and alveolar macrophage whole-genome responses. Results: We found that the gut microbiota protects the host during pneumococcal pneumonia, as reflected by increased bacterial dissemination, inflammation, organ damage and mortality in microbiota-depleted mice compared with controls. FMT in gut microbiota-depleted mice led to a normalisation of pulmonary bacterial counts and tumour necrosis factor-α and interleukin-10 levels 6 h after pneumococcal infection. Whole-genome mapping of alveolar macrophages showed upregulation of metabolic pathways in the absence of a healthy gut microbiota. This upregulation correlated with an altered cellular responsiveness, reflected by a reduced responsiveness to lipopolysaccharide and lipoteichoic acid. Compared with controls, alveolar macrophages derived from gut microbiota-depleted mice showed a diminished capacity to phagocytose S. pneumoniae . Conclusions: This study identifies the intestinal microbiota as a protective mediator during pneumococcal pneumonia. The gut microbiota enhances primary alveolar macrophage function. Novel therapeutic strategies could exploit the gut–lung axis in bacterial infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2015-309728

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Protective role of the gut microbiota during pneumococcal pneumonia. (A) Experimental design. Group of eight wild-type mice were treated for 3 weeks with broad-spectrum antibiotics (ampicillin, neomycin, metronidazole and vancomycin) in their drinking water compared with untreated controls. Two days post treatment mice received an intranasal challenge with 1×106 colony forming units (CFU) of Streptococcus pneumoniae. Subsequently, mouse survival, bacterial outgrowth and cytokine release were determined at various time points post S. pneumoniae infection. (B) Survival of mice treated with broad-spectrum antibiotics compared with untreated controls before intranasal challenge with 1×106 CFU of S. pneumoniae. (C) Pulmonary bacterial counts 6 h after S. pneumoniae infection in untreated (black) and microbiota-depleted (white) mice. (D) Blood bacterial counts 48 h after S. pneumoniae infection in untreated (black) and microbiota-depleted (white) mice. (E) Representative small intestine sections of untreated (upper row) and microbiota-depleted (lower row) mice demonstrate intact epithelial integrity with H&E, Ki67 (proliferation restricted in the crypt), MUC2 (goblet cell differentiation) and ChromograninA (neuroendocrine cell differentiation) stainings in both groups. (F) Effect of faecal microbiota transplantation to gut microbiota-depleted mice on lung bacterial counts 6 h after intranasal S. pneumoniae infection. (G) The magnitude by which the antibiotic protocol depleted the gut microbiota was assessed using a phylogenetic microarray in which microbiota composition samples were clustered based on principal component analysis (PCA), (H) Pearson Clustering and (I) the Shannon Diversity Index. Group size is 8–12 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05.
Figure 1 Protective role of the gut microbiota during pneumococcal pneumonia. (A) Experimental design. Group of eight wild-type mice were treated for 3 weeks with broad-spectrum antibiotics (ampicillin, neomycin, metronidazole and vancomycin) in their drinking water compared with untreated controls. Two days post treatment mice received an intranasal challenge with 1×106 colony forming units (CFU) of Streptococcus pneumoniae. Subsequently, mouse survival, bacterial outgrowth and cytokine release were determined at various time points post S. pneumoniae infection. (B) Survival of mice treated with broad-spectrum antibiotics compared with untreated controls before intranasal challenge with 1×106 CFU of S. pneumoniae. (C) Pulmonary bacterial counts 6 h after S. pneumoniae infection in untreated (black) and microbiota-depleted (white) mice. (D) Blood bacterial counts 48 h after S. pneumoniae infection in untreated (black) and microbiota-depleted (white) mice. (E) Representative small intestine sections of untreated (upper row) and microbiota-depleted (lower row) mice demonstrate intact epithelial integrity with H&E, Ki67 (proliferation restricted in the crypt), MUC2 (goblet cell differentiation) and ChromograninA (neuroendocrine cell differentiation) stainings in both groups. (F) Effect of faecal microbiota transplantation to gut microbiota-depleted mice on lung bacterial counts 6 h after intranasal S. pneumoniae infection. (G) The magnitude by which the antibiotic protocol depleted the gut microbiota was assessed using a phylogenetic microarray in which microbiota composition samples were clustered based on principal component analysis (PCA), (H) Pearson Clustering and (I) the Shannon Diversity Index. Group size is 8–12 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05.CC BY-NC · PubMed Central
Figure 2 The gut microbiota protects against organ failure during Streptococcus pneumoniae-induced sepsis. (A–C) Representative lung slides of untreated (left) and microbiota-depleted (right) mice infected with 1×106 colony forming units (CFU) of S. pneumoniae via the intranasal route and euthanised at indicated time points (6, 24 and 48 h) thereafter to assess pulmonary inflammation and total lung histopathology scores (see Materials and methods). H&E staining; original magnification, ×100. (D and E) Liver and spleen histology shown 48 h after infection. H&E staining; original magnification, ×200 for liver, ×100 for spleen. (F) Systemic blood urea nitrogen (BUN), (G) aspartate aminotransferase (AST), (H) alanine aminotransferase (ALT) and (I) lactate dehydrogenase (LDH) levels assessed 48 h after infection in untreated (black) and gut microbiota-depleted (white) mice. Group size is 8 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05 and **p<0.01.
Figure 2 The gut microbiota protects against organ failure during Streptococcus pneumoniae-induced sepsis. (A–C) Representative lung slides of untreated (left) and microbiota-depleted (right) mice infected with 1×106 colony forming units (CFU) of S. pneumoniae via the intranasal route and euthanised at indicated time points (6, 24 and 48 h) thereafter to assess pulmonary inflammation and total lung histopathology scores (see Materials and methods). H&E staining; original magnification, ×100. (D and E) Liver and spleen histology shown 48 h after infection. H&E staining; original magnification, ×200 for liver, ×100 for spleen. (F) Systemic blood urea nitrogen (BUN), (G) aspartate aminotransferase (AST), (H) alanine aminotransferase (ALT) and (I) lactate dehydrogenase (LDH) levels assessed 48 h after infection in untreated (black) and gut microbiota-depleted (white) mice. Group size is 8 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05 and **p<0.01.CC BY-NC · PubMed Central
Figure 3 Effect of intestinal microbiota depletion on the alveolar macrophage transcriptome. (A) Unsupervised hierarchical clustering heatmap of the significant (multiple comparison adjusted p<0.05) differentially expressed genes between untreated control and gut microbiota-depleted lung alveolar macrophages. Red denotes increased expression; blue denotes decreased expression. (B) Stacked bar plot depicting the significantly enriched canonical signalling pathways (ingenuity pathway analysis) and expression patterns. –log(B–H)p, negative log-transformed Benjamini–Hochberg-adjusted Fisher test p value. Ratio, ratio of input genes to pathway genes. Red denotes increased expression in gut microbiota-depleted alveolar macrophages; green denotes decreased expression in gut microbiota-depleted alveolar macrophages.
Figure 3 Effect of intestinal microbiota depletion on the alveolar macrophage transcriptome. (A) Unsupervised hierarchical clustering heatmap of the significant (multiple comparison adjusted p<0.05) differentially expressed genes between untreated control and gut microbiota-depleted lung alveolar macrophages. Red denotes increased expression; blue denotes decreased expression. (B) Stacked bar plot depicting the significantly enriched canonical signalling pathways (ingenuity pathway analysis) and expression patterns. –log(B–H)p, negative log-transformed Benjamini–Hochberg-adjusted Fisher test p value. Ratio, ratio of input genes to pathway genes. Red denotes increased expression in gut microbiota-depleted alveolar macrophages; green denotes decreased expression in gut microbiota-depleted alveolar macrophages.CC BY-NC · PubMed Central
Figure 4 The gut microbiota enhances primary alveolar macrophage function. (A) Capacity of alveolar macrophages derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose Streptococcus pneumoniae ex vivo for 30 min. (B) Capacity of whole-blood neutrophils derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose S. pneumoniae ex vivo for 30 min. (C) Capacity of peritoneal macrophages derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose S. pneumoniae ex vivo for 10 and 30 min. (D and E) Responsiveness of alveolar macrophages derived from gut microbiota-depleted (white) mice and control (black) mice towards lipoteichoic acid (LTA) and (F and G) lipopolysaccharide (LPS) in terms of interleukin (IL)-6 and tumour necrosis factor (TNF)-α production. (H) TNF-α production of whole blood derived from gut microbiota-depleted (white) mice and control (black) mice upon stimulated with LPS. (I and J) LTA-stimulated peritoneal macrophages derived from gut microbiota-depleted mice (white) and controls (black). (K and L) LPS-stimulated peritoneal macrophages derived from gut microbiota-depleted mice (white) and controls (black). Group size is 8 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05, **p<0.01 and ***p<0.001.
Figure 4 The gut microbiota enhances primary alveolar macrophage function. (A) Capacity of alveolar macrophages derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose Streptococcus pneumoniae ex vivo for 30 min. (B) Capacity of whole-blood neutrophils derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose S. pneumoniae ex vivo for 30 min. (C) Capacity of peritoneal macrophages derived from gut microbiota-depleted (white) mice and control (black) mice to phagocytose S. pneumoniae ex vivo for 10 and 30 min. (D and E) Responsiveness of alveolar macrophages derived from gut microbiota-depleted (white) mice and control (black) mice towards lipoteichoic acid (LTA) and (F and G) lipopolysaccharide (LPS) in terms of interleukin (IL)-6 and tumour necrosis factor (TNF)-α production. (H) TNF-α production of whole blood derived from gut microbiota-depleted (white) mice and control (black) mice upon stimulated with LPS. (I and J) LTA-stimulated peritoneal macrophages derived from gut microbiota-depleted mice (white) and controls (black). (K and L) LPS-stimulated peritoneal macrophages derived from gut microbiota-depleted mice (white) and controls (black). Group size is 8 per group; results are shown as means±SEM; n.s. denotes not significant; *p<0.05, **p<0.01 and ***p<0.001.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. 10.1172/JCI200215277 · doi:10.1172/jci200215277

Cited by

See all 832

Metadata

Authors
Schuijt, T. J., Lankelma, J. M., Scicluna, B. P., de Sousa e Melo, F., Roelofs, J. J. T. H., de Boer, J. D., Hoogendijk, A. J., de Beer, R., de Vos, A., Belzer, C., de Vos, W. M., van der Poll, T., & Wiersinga, W. J.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • Wageningen University & Research (NL)
  • Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands
Corresponding author
Wiersinga, W Joost
Venue
Gut
Publisher
BMJ
Published
2015-10-28
Volume
65
Issue
4
Pages
575-583
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2175568660
Cited by
832
References
47
Citations by year
2026: 59 · 2025: 90 · 2024: 90 · 2023: 83 · 2022: 104 · 2021: 93 · 2020: 107 · 2019: 61 · 2018: 59 · 2017: 54 · 2016: 28 · 2015: 3
FWCI
20.72
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion, cc-by-nc)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • OAR@UM (University of Malta) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc)
Funders
  • ZonMw
  • Universiteit van Amsterdam
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
gut microbiota, pneumococcal pneumonia, Streptococcus pneumoniae, alveolar macrophages, gut-lung axis, fecal microbiota transplantation, microbiota depletion, phagocytosis, lipopolysaccharide response, lipoteichoic acid, TNF-α, IL-10, inflammation, bacterial dissemination, host defense
MeSH terms
Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Feces, Mice, Inbred C57BL, Pneumonia, Pneumococcal, Streptococcus pneumoniae, Tumor Necrosis Factor-alpha, Up-Regulation, Macrophages, Alveolar, Interleukin-10, Sepsis, Immunity, Mucosal, Mice, Bacterial Load, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. https://app.cochat.ai/papers/10.1136/gutjnl-2015-309728
The paper
Schuijt, T. J., Lankelma, J. M., Scicluna, B. P., de Sousa e Melo, F., Roelofs, J. J. T. H., de Boer, J. D., Hoogendijk, A. J., de Beer, R., de Vos, A., Belzer, C., de Vos, W. M., van der Poll, T., & Wiersinga, W. J. (2016). The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. https://doi.org/10.1136/gutjnl-2015-309728

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.